AZN Quote, Trading Chart, Astrazeneca PLC

$55.51 Last:

2.47% Change Percent:

$54.2 Open:

$55.51 Previous Close:

$55.84 High:

$54.02 Low:

4,954,076 Volume:

09/25/2020 04:55:24 pm Last Trade Date Time:

Quotes are delayed by 15 to 20 minutes.

Stock Date	Open Price	Close Price	High	Low	Volume
2020-09-25	54.2	55.51	55.84	54.02	4,954,076
2020-09-24	54.94	54.17	55.16	53.92	4,105,524
2020-09-23	56.22	55.66	56.585	55.575	2,921,256
2020-09-22	55.29	55.44	55.62	54.72	3,875,256
2020-09-21	55.09	55.91	55.91	54.62	6,790,555
2020-09-18	56.76	56.45	56.8	55.96	2,917,700
2020-09-17	55.74	55.94	56.15	55.49	3,988,831
2020-09-16	55.72	55.13	55.98	55.11	3,947,483
2020-09-15	55.53	55.28	55.78	55.1215	4,293,772
2020-09-14	54.23	54.02	54.34	53.37	4,957,099
2020-09-11	53.99	53.73	54.15	53.405	4,622,922
2020-09-10	54.16	53.07	54.19	53.04	4,395,719
2020-09-09	53.83	53.64	54.82	53.34	11,393,183
2020-09-08	54.14	54.71	54.94	53.76	6,061,847
2020-09-07	53.79	53.58	54.14	52.57	4,610,026
2020-09-04	53.79	53.58	54.14	52.57	4,604,146
2020-09-03	55.35	54.16	55.5	53.61	5,103,499
2020-09-02	55.47	55.9	55.99	55.27	3,597,085
2020-09-01	55.85	55.38	55.9	55.12	3,924,166
2020-08-31	55.8	56	56.34	55.61	3,162,291

Stock Information

Astrazeneca PLC Company Name:

AZN Stock Symbol:

NYSE Market:

Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...

AZN - AstraZeneca aims to transform cancer care with practice-changing data at ASCO 2022

ENHERTU ® (fam-trastuzumab deruxtecan-nxki) data will show the potential to improve survival for metastatic breast cancer patients and define a new segment of HER2-low disease Results from multiple trials further reinforce strength of industry-leading portfo...
AZN - 5 Stocks to Buy for the Coming Recession

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Each of these stocks to buy are low-beta stocks with attractive dividend yields to help endure a recession. AstraZeneca ( AZN ): Strong growth visibility with a deep pipeline of drug candidates. A healthy dividend ...
AZN - PT027, a Novel Fixed-Dose Combination of Albuterol and Budesonide, Used as an As-Needed Rescue Medicine, Significantly Reduced the Risk of a Severe Exacerbation Compared to Albuterol by 27% in Patients With Asthma

First time an albuterol/budesonide fixed-dose combination rescue medication has been shown to reduce severe exacerbations MANDALA Phase III trial results published in the New England Journal of Medicine and presented at ATS 2022 International Conference Full ...